A research team from Queen’s has been awarded a £500,000 UK Research and Innovation (UKRI) Rapid Response Fund grant to investigate the role of bacterial co-infections in COVID-19, and drug repurposing for the treatment of the disease.
Research led by Queen’s University has found a new way through which the p53 gene, also known as the ‘Guardian of the Genome’, the most frequently mutated gene in cancer, can prevent cell death in colorectal
The Precision Medicine Centre of Excellence (PMC) at Queen’s is leading a ground-breaking collaboration with the world’s largest biotech company Roche, and Artificial Intelligence (AI) specialist, Sonrai Analytics.
COVID-19 has had a significant impact not just in terms of the immediate effects of the disease, but across a whole spectrum of aspects of our lives.
Queen’s University Belfast is leading a UK-wide trial called ‘Seroprevalence of SARS-Cov-2 infection in healthy children’ to measure antibodies to SARS-CoV-2 (COVID-19) in healthy children.
A team of researchers from Queen’s University have identified new problems linked to the disease and warn of a sharp rise in antimicrobial resistance associated to COVID-19 treatments in the aftermath of the pandemic.
Research led by Queen’s has found that kidney transplantation is the optimum treatment for people with chronic kidney disease, improving both their quality of life and long-term survival, whilst also costing less than alternative treatments.
Queen’s Pro Vice-Chancellor for the Faculty of Medicine, Health and Life Sciences, Professor Stuart Elborn, is among 50 of the UK’s most prominent biomedical and health scientists elected to The Academy of Medical Sciences’ prestigious Fellowship.
Queen’s University Belfast has received funding to conduct a trial with the aim of developing a rapid diagnostic test for COVID-19.
Scientists are calling on the public to sign up to a new study which will help identify who is most at risk of contracting COVID-19 and why some people become more ill than others with the disease.
For the first time, over two hundred medical students at Queen’s University recited the Sponsio Academica virtually, as they embark on their careers early in order to aid the health service during the COVID-19 pandemic.
Two researchers in the School of Medicine, Dentistry and Biomedical Sciences have been awarded Future Leaders Fellowships as part of a new investment announced by UK Research and Innovation (UKRI).
A new clinical trial led by Queen’s University Belfast and the University of Warwick seeks to find alternatives to ventilators to treat patients who are critically ill with COVID-19.
Fusion Antibodies announces that the Company is working with Queen’s as part of The Northern Ireland Coronavirus Antibody Development Alliance (“NICADA”).
Researchers at Queen’s University Belfast are leading a UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure.
The Queen’s University N.Ireland Cancer Registry (NICR) today (Thursday 2 April) released the number of cancer incidence and survival statistics in Northern Ireland during 1993-2018.
Queen’s University Belfast has a proud tradition in Cancer Research and its translation into improving the lives of our citizens, locally, nationally and internationally.
Prostate Cancer UK and Movember have awarded £1.25m to Queen’s and The University of Manchester to continue advancing treatment for prostate cancer as part of the Belfast-Manchester Centre of Excellence.
Congratulations to Dr Karl Butterworth from The Patrick G Johnston Centre for Cancer Research has won a highly prestigious international award from the Radiation Research Society in the United States.
Congratulations to Queen’s University research experts who were named in the UK’s top 25 most influential researchers who study diabetes complications.
A leading scientist from Queen’s University Belfast has been awarded over £855,000 from Cancer Research UK to find new ways to prevent oesophageal cancer and improve survival rates.
Researchers at Queen’s University Belfast have discovered a new way to analyse bowel cancer tumours, which could lead to more personalised treatments and better prognosis for patients.
People from both sides of the border will benefit from new health and social care research trials thanks to a new Cross-Border Healthcare Intervention Trials in Ireland Network (CHITIN).
Queen’s University Belfast is delighted to announce two special events taking place in October 2018 to celebrate World Sight Day which provide a platform to promote the advancement of knowledge and treatment of diabetic eye disease and AMD.
Queen’s University Belfast will hosting AIMday Big Data, AI and the One Health Agenda on Friday 19th October 2018 at Riddel Hall, Queen’s University Belfast.
A groundbreaking report, led by Professor Mark Lawler, Chair in Translational Cancer Genomics at Queen’s highlights a plan to end bowel cancer, the second most common cause of cancer death in Europe.
A £10million Centre of Excellence in Precision Medicine has been launched by Invest Northern Ireland and Queen’s University Belfast.
ICAT seeks to appoint 8 qualified and ambitious medical graduates who aspire to become the next generation of clinical academic leaders. Applications must be submitted by 16.00 GMT, 31 October 2017
ICAT seeks to appoint the first cohort of 8 well qualified and ambitious medical graduates who aspire to become the next generation of clinical academic leaders.
Researchers from Queen’s University and the Institute of Cancer Research in London have received a grant of over £819,000 from Prostate Cancer UK to test a new potential treatment for advanced prostate cancer.
Researchers at Queen’s University Belfast have begun a £2 million research programme to investigate reversing the damage caused by Multiple Sclerosis.
An international research team, led by public health experts at Queen’s University Belfast, have conducted the first ever study into the impact of the built environment on levels of exercise and physical activity among people in India.
Researchers at Queen's University Belfast and University College London have discovered that a drug, originally developed to treat cardiovascular disease, has the potential to reduce diabetes related blindness.
Dentistry at Queen’s University Belfast is now ranked as the top Dentistry course in the UK. The latest Guardian rankings have announced that Dentistry at Queen’s has moved to 1st place after ranking 2nd in previous years.
World-leading researchers from Queen’s University Belfast are among a team of scientists from the USA and Ireland who are collaborating to develop a novel treatment for diabetes-related blindness.
Researchers at Queen’s are leading a €50 million, Europe-wide, project to develop new drug treatments that could improve the lives of patients with cystic fibrosis and bronchiectasis.